0801 ET - Citi downgrades CME Group to neutral from buy, saying a number a positive catalysts have recently played out for the derivatives marketplace. In a research note, Citi says it expects more muted top-line growth for CME this year after two years of double-digit revenue growth. Citi says that while it expects CME shares to hold, given the company's defensive qualities in what the analysts expect to be a volatile environment, it prefers to wait for a better entry point and/or clearer fundamental catalysts to put new money to work. Citi's CME target price goes to $250 from $255. CME Group down 0.1% premarket to $232.07. (colin.kellaher@wsj.com)

(END) Dow Jones Newswires

January 06, 2025 08:01 ET (13:01 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.